Evaluation of the Efficiency of Biofield Diagnostic System in Breast Cancer Detection Using Clinical Study Results and Classifiers
- 208 Downloads
The division of breast cancer cells results in regions of electrical depolarisation within the breast. These regions extend to the skin surface from where diagnostic information can be obtained through measurements of the skin surface electropotentials using sensors. This technique is used by the Biofield Diagnostic System (BDS) to detect the presence of malignancy. This paper evaluates the efficiency of BDS in breast cancer detection and also evaluates the use of classifiers for improving the accuracy of BDS. 182 women scheduled for either mammography or ultrasound or both tests participated in the BDS clinical study conducted at Tan Tock Seng hospital, Singapore. Using the BDS index obtained from the BDS examination and the level of suspicion score obtained from mammography/ultrasound results, the final BDS result was deciphered. BDS demonstrated high values for sensitivity (96.23%), specificity (93.80%), and accuracy (94.51%). Also, we have studied the performance of five supervised learning based classifiers (back propagation network, probabilistic neural network, linear discriminant analysis, support vector machines, and a fuzzy classifier), by feeding selected features from the collected dataset. The clinical study results show that BDS can help physicians to differentiate benign and malignant breast lesions, and thereby, aid in making better biopsy recommendations.
KeywordsBreast cancer Electropotentials Biofield Diagnostic System Classifiers Clinical Study
Conflict of interest statement
- 1.SEER Cancer Statistics Review 1975–2006, National Cancer Institute. Information available at http://seer.cancer.gov/csr/1975_2006/results_single/sect_01_table.01.pdf (last accessed Jan 2010).
- 2.Ng, E. Y.-K., Vinitha Sree, S., Ng, K. H., and Kaw, G., The use of tissue electrical characteristics for breast cancer detection: a perspective review. Tech. Cancer Res. Treat. 7(4):295–308, 2008.Google Scholar
- 3.Biofield Diagnostic System. Information available at http://www.mackaylifesciences.com/products.html (last accessed Jan 2010).
- 4.Vinitha Sree, S., Ng, E. Y.-K., Kaw, G., Rajendra Acharya, U., and Chong, B. K., The use of skin surface electropotentials for breast cancer detection: preliminary clinical trial results obtained using the Biofield Diagnostic System. J. Med. Syst., 2009. doi: 10.1007/s10916-009-9343-0.Google Scholar
- 5.Davies, R. J., Underlying mechanism involved in surface electrical potential measurements for the diagnosis of breast cancer: an electrophysiological approach to breast cancer. In: Dixon, J. M. (Ed.), Electropotentials in The Clinical Assessment of Breast Neoplasia. Springer, New York, pp. 4–17, 1996.Google Scholar
- 8.Weiss, B. A., Ganpola, G. A. P., Freeman, H. P., Hsu, Y.-S., and Faupel, M. L., Surface electrical potentials as a new modality in the diagnosis of breast lesions: a preliminary report. Breast Dis. 7(2):91–98, 1994.Google Scholar
- 9.Faupel, M. L., and Hsu, Y.-S., Dedicated systems for surface electropotential evaluation in the detection and diagnosis of neoplasia. In: Dixon, J. M. (Ed.), Electropotentials in the Clinical Assessment of Breast Neoplasia. Springer, Berlin, pp. 37–44, 1995.Google Scholar
- 12.Faupel, M., Barrett, B., Stephens, J., and Nathanson, S., inventors; Biofield Corp., assignee. D.C biopotential sensing electrode and electroconductive medium for use therein. United States patent US 5823957. 1998 Oct 20.Google Scholar
- 14.Cuzick, J., Davies, R., Stephens, J., Borgwardt, V., Housworth, C., Lei, X., Gadsby, P., and Iskac, A., inventors; Biofield Corp., assignee. Method and apparatus for sensing and processing biopotentials. United States patent US 6351666. 2002 Feb 26.Google Scholar
- 17.Biofield Diagnostic System, Physician’s manual. Manual No. Dossier463_617_389 rev 1. Google Scholar
- 18.Sacchini, V., Gatzemeier, W., Costa, A., Merson, M., Bonanni, B., Gennaro, M., Zandonini, G., Gennari, R., Holland, R., Schreer, I., and Vanel, D., Utility of biopotentials measured with the Biofield Diagnostic System for distinguishing malignant from benign lesions and proliferative from nonproliferative benign lesions. Breast Cancer Res. Treat. 76:S116, 2002.Google Scholar
- 19.Imaginis. Information available at http://www.imaginis.com/breasthealth/performbse.asp (last accessed Jan 2010).
- 20.MedCalc statistical software. Information available at http://www.medcalc.be/ (last accessed Jan 2010).
- 23.Crowe, S. S., and Faupel, M. L., Use of non-directed (screening) arrays in the evaluation of symptomatic and asymptomatic breast patients. In: Dixon, J. M. (Ed.), Electropotentials in the Assessment of Breast Neoplasia. Springer, Berlin, pp. 52–62, 1995.Google Scholar